Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
27
datasets available to search
ShareScore release 0.9.0
Dataset results
27 results for “glibenclamide”
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
ClinicalTrials.gov study NCT02864953. IPD Sharing: NO. Countries: 24. Publications: 2.
Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes
ClinicalTrials.gov study NCT01822548. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
ClinicalTrials.gov study NCT02145611. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
The Hemodynamics Effect of Glibenclamide on Levcromakalim Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study Wi
ClinicalTrials.gov study NCT03886922. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus Ltd. )
ClinicalTrials.gov study NCT03855306. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT03569540. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism
ClinicalTrials.gov study NCT03284463. IPD Sharing: NO. Countries: 1. Publications: 2.
Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM
ClinicalTrials.gov study NCT00417729. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluate the Use of Glibenclamide on Acute aSAH
ClinicalTrials.gov study NCT05137678. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
ClinicalTrials.gov study NCT02318693. IPD Sharing: YES. Countries: 0. Publications: 1.
Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01867502. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS
ClinicalTrials.gov study NCT02080377. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage
ClinicalTrials.gov study NCT03741530. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Low dosE GlibENclamide in Diabetes Part A
ClinicalTrials.gov study NCT02830048. IPD Sharing: YES. Countries: 1. Publications: 1.
Figure 1 from: Mohammad JA, Almulathanon AAY, Fathi FH (2021) Assessment of the effects of metformin and glibenclamide on the concentration of selected trace elements in type 2 diabetic patients. Pharmacia 68(4): 845-849. https://doi.org/10.3897/pharmacia.68.e72080
Figure 1 Effects of metformin versus glibenclamide on serum concentrations of A) Cu, B) Zn, and C) Mg in type 2 diabetic patients.* indicates statistically significant differences compared to the control group (**p < 0.01; ***p < 0.001; ****p < 0.0001); # indicates statistically significant differences compared to the newly diagnosed group (#p < 0.05; ###p < 0.001); $ indicates statistically significant differences between the metformin and glibenclamide treated groups, as determined by the Kruskal-Wallis test followed by a Dunn's multiple comparisons post-hoc test.
Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients
ClinicalTrials.gov study NCT05688332. IPD Sharing: YES. Countries: 0. Publications: 4.
To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI
ClinicalTrials.gov study NCT05148403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
ClinicalTrials.gov study NCT05687500. IPD Sharing: NO. Countries: 1. Publications: 0.
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
ClinicalTrials.gov study NCT07221799. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacogenetic Effect on the Pharmacodynamics of Glibenclamide
ClinicalTrials.gov study NCT01242137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.